TL;DR
This study investigates whether using neuronavigation guided by transcranial magnetic stimulation (nTMS)-informed tractography (TIT) can improve surgical outcomes for glioblastomas located near the motor cortex. The findings suggest that TIT-guided surgery leads to more complete tumor removal (GTR) without significantly increasing motor deficits, ultimately contributing to longer patient survival.
What Problem Does This Paper Address?
Glioblastomas in or near the primary motor cortex (M1) and corticospinal tract (CST) pose a significant surgical challenge. The dilemma lies in balancing the potential for improved survival through aggressive tumor resection (Gross Total Resection, GTR) against the risk of causing permanent motor deficits, which can impair quality of life and eligibility for adjuvant therapies. Traditional imaging methods can struggle to accurately delineate the CST in the presence of tumor mass effect and anatomical shifts. This study aims to determine if a more advanced technique, TIT, can help neurosurgeons navigate these challenges more effectively.
Methods
The researchers conducted a retrospective, single-center cohort study comparing 61 patients with primary glioblastomas near the motor eloquent areas. Thirty-five patients (Group T) received surgery guided by nTMS-informed tractography (TIT), while 26 control patients (Group C) did not.
Key methodological aspects include:
- nTMS-Informed Tractography (TIT): This technique uses navigated transcranial magnetic stimulation (nTMS) to map the motor cortex. These functional maps then serve as starting points for Diffusion Tensor Imaging (DTI) tractography to reconstruct the individual corticospinal tract (CST).
- Propensity Score Matching (PSM): To ensure a fair comparison between the TIT and control groups, PSM was used to balance patient and tumor characteristics (like preoperative tumor volume and proximity to the insula) between the groups. This helps to minimize bias from confounding factors.
- Surgical Outcome Assessment: The primary outcome was the extent of resection, specifically Gross Total Resection (GTR). Secondary outcomes included gross motor functional changes and overall survival (Progression-Free Survival, PFS, and Overall Survival, OS).
- Statistical Analysis: A rigorous statistical approach was employed, including univariate and multivariate regression analyses, stepwise model simplification (using AIC), and pairwise comparisons within the PSM-matched cohorts.
Datasets
The study utilized retrospective data from 61 patients treated at a single institution between July 2010 and May 2015. The dataset included:
- Preoperative MRI scans (T1w with and without contrast, T2-weighted, FLAIR, DTI).
- Postoperative MRI scans.
- Clinical data including age, gender, preoperative motor status, Karnofsky Performance Status (KPS), MGMT promoter methylation status, and IDH1/2 mutation status.
- Data on surgical interventions, including the use of 5-ALA fluorescence, neuronavigation, and intraoperative neuromonitoring.
- nTMS and DTI data for the TIT group.
No new benchmarks were introduced; the study focused on analyzing existing patient data.
Key Insights and Ideas
- TIT Enhances CST Visualization: TIT provides a more precise and individualized map of the CST, which is crucial for planning surgery near this critical motor pathway.
- GTR is Key for Survival: The study strongly reinforces that achieving Gross Total Resection (GTR) is the most significant predictor of improved Progression-Free Survival (PFS) and Overall Survival (OS) in glioblastoma patients, even in motor-eloquent areas.
- Balancing Risk and Benefit: The core finding is that TIT-guided surgery allows for more aggressive resection (higher GTR rates) in challenging locations without a statistically significant increase in motor deficits, suggesting the benefits outweigh the risks.
- Individualized Planning Matters: The study highlights the importance of comprehensive, individualized surgical planning, with TIT playing a key role in informing these decisions.
Key Results
- Higher GTR Rates with TIT: In PSM-matched comparisons, patients who underwent TIT-guided surgery achieved significantly higher GTR rates (77% vs. 69% in the full matched cohort, and 87% vs. 78% in the subgroup with intended GTR).
- Prolonged Survival: TIT-guided GTR was associated with a significant increase in PFS (p=0.030) in the subgroup with intended GTR. GTR itself was the strongest predictor of both PFS and OS.
- Motor Function Maintained: Despite a higher overlap with the CST in the TIT group, there was no significant difference in the change of gross motor function or KPS between the TIT and control groups.
- CST Overlap Predicts Deficits: Higher CST overlap with the tumor was identified as the best predictor of postoperative gross motor function worsening.
Limitations and Future Work
- Non-Randomized Design: The study is retrospective and non-randomized, which inherently introduces potential biases. The authors acknowledge that patients with tumors closer to the CST were more likely to receive TIT, creating a confound.
- Limited Sample Size: While PSM was used, the relatively small sample size (n=61) limits the statistical power for detecting subtle differences, particularly in motor outcomes.
- DTI Data Availability: Direct individual tractography comparison between groups was not possible as DTI was primarily performed for the TIT group. A standard CST template was used for group comparisons, which is less precise than individual tractography.
- Future Work: The authors suggest that a prospective randomized controlled trial is needed to definitively prove the benefits of TIT in glioblastoma surgery. They also mention that advancements in intraoperative mapping techniques (like continuous dynamic mapping) could further improve outcomes.
Summary updated